166 related articles for article (PubMed ID: 11967726)
1. Angiotensin II as a cardiovascular risk factor.
Gavras I; Gavras H
J Hum Hypertens; 2002 May; 16 Suppl 2():S2-6. PubMed ID: 11967726
[TBL] [Abstract][Full Text] [Related]
2. A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury.
du Toit EF; Nabben M; Lochner A
Basic Res Cardiol; 2005 Jul; 100(4):346-54. PubMed ID: 15821998
[TBL] [Abstract][Full Text] [Related]
3. RAA system and cardiovascular control in normal subjects, hypertensives and patients with congestive heart failure.
Seravalle G; Cattaneo BM; Giannattasio C; Perondi R; Saino A; Grassi G; Mancia G
J Hum Hypertens; 1993 Aug; 7 Suppl 2():S13-8. PubMed ID: 8230084
[TBL] [Abstract][Full Text] [Related]
4. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy].
Castro-Chaves P; Leite-Moreira AF
Rev Port Cardiol; 2004 May; 23 Suppl 2():II61-77. PubMed ID: 15222251
[TBL] [Abstract][Full Text] [Related]
5. The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function.
Qian C; Schoemaker RG; van Gilst WH; Roks AJ
Clin Sci (Lond); 2009 Feb; 116(4):301-14. PubMed ID: 19138171
[TBL] [Abstract][Full Text] [Related]
6. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
7. Vascular angiotensin pathways: a new therapeutic target.
Dzau VJ
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S9-16. PubMed ID: 2485070
[TBL] [Abstract][Full Text] [Related]
8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
9. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
de Resende MM; Mill JG
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor blockers in the treatment of the cardiovascular disease continuum.
Chrysant SG
Clin Ther; 2008; 30 Pt 2():2181-90. PubMed ID: 19281913
[TBL] [Abstract][Full Text] [Related]
11. The renin-angiotensin system does not contribute to the endothelial dysfunction and increased infarct size in rats exposed to second hand smoke.
Zhu BQ; Sievers RE; Browne AE; Hillman RT; Chair K; Lee RJ; Chatterjee K; Glantz SA; Parmley WW
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):54-60. PubMed ID: 11984749
[TBL] [Abstract][Full Text] [Related]
12. The role of the renin-angiotensin system in the pathophysiology, prevention, and treatment of renal impairment in patients with the cardiometabolic syndrome or its components.
Alpert MA; Govindarajan G; Del Rosario ML; Reisin E
J Cardiometab Syndr; 2009; 4(1):57-62. PubMed ID: 19245518
[TBL] [Abstract][Full Text] [Related]
13. Renin-angiotensin system and atherothrombotic disease: from genes to treatment.
Jacoby DS; Rader DJ
Arch Intern Med; 2003 May; 163(10):1155-64. PubMed ID: 12767951
[TBL] [Abstract][Full Text] [Related]
14. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
15. [Role of angiotensin in the metabolic syndrome and cardiovascular complications].
Rakugi H; Ogihara T
Nihon Rinsho; 2002 Oct; 60(10):1898-903. PubMed ID: 12397681
[TBL] [Abstract][Full Text] [Related]
16. Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors.
Galderisi M; de Divitiis O
J Cardiovasc Pharmacol; 2008 Jun; 51(6):523-31. PubMed ID: 18520954
[TBL] [Abstract][Full Text] [Related]
17. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
[TBL] [Abstract][Full Text] [Related]
18. Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics.
Prosser HC; Forster ME; Richards AM; Pemberton CJ
Cardiovasc Res; 2009 Apr; 82(1):40-50. PubMed ID: 19147651
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II-dependent vascular alterations in young cardiomyopathic hamsters: role for oxidative stress.
Escobales N; Crespo MJ
Vascul Pharmacol; 2006 Jan; 44(1):22-8. PubMed ID: 16301003
[TBL] [Abstract][Full Text] [Related]
20. The intracellular renin-angiotensin system: implications in cardiovascular remodeling.
Kumar R; Singh VP; Baker KM
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):168-73. PubMed ID: 18277150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
